大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/03/05 | 4,855 | 4,860 | 4,605 | 4,610 | -85 | -1.8% | 254,800 |
| 2020/03/04 | 4,740 | 4,815 | 4,575 | 4,695 | -35 | -0.7% | 276,300 |
| 2020/03/03 | 4,655 | 4,920 | 4,640 | 4,730 | +235 | +5.2% | 553,400 |
| 2020/03/02 | 4,435 | 4,590 | 4,305 | 4,495 | -65 | -1.4% | 346,300 |
| 2020/02/28 | 4,720 | 4,860 | 4,505 | 4,560 | -370 | -7.5% | 479,600 |
| 2020/02/27 | 4,930 | 5,190 | 4,900 | 4,930 | +40 | +0.8% | 458,200 |
| 2020/02/26 | 5,180 | 5,200 | 4,870 | 4,890 | -380 | -7.2% | 464,500 |
| 2020/02/25 | 5,360 | 5,440 | 5,120 | 5,270 | +285 | +5.7% | 705,900 |
| 2020/02/21 | 5,030 | 5,160 | 4,900 | 4,985 | -245 | -4.7% | 778,100 |
| 2020/02/20 | 5,180 | 5,540 | 4,925 | 5,230 | +80 | +1.6% | 814,600 |
| 2020/02/19 | 5,580 | 5,580 | 4,985 | 5,150 | -530 | -9.3% | 1,290,400 |
| 2020/02/18 | 6,400 | 6,500 | 5,650 | 5,680 | -330 | -5.5% | 1,828,200 |
| 2020/02/17 | 5,200 | 6,010 | 5,160 | 6,010 | +1,000 | +20% | 2,369,900 |
| 2020/02/14 | 5,170 | 5,170 | 4,820 | 5,010 | +155 | +3.2% | 1,131,900 |
| 2020/02/13 | 4,650 | 5,230 | 4,615 | 4,855 | +310 | +6.8% | 2,510,900 |
| 2020/02/12 | 4,530 | 4,545 | 4,445 | 4,545 | +700 | +18.2% | 1,019,000 |
| 2020/02/10 | 4,060 | 4,100 | 3,815 | 3,845 | -100 | -2.5% | 386,800 |
| 2020/02/07 | 3,740 | 3,965 | 3,735 | 3,945 | +210 | +5.6% | 276,900 |
| 2020/02/06 | 3,725 | 3,795 | 3,680 | 3,735 | +10 | +0.3% | 156,500 |
| 2020/02/05 | 3,700 | 3,820 | 3,635 | 3,725 | -25 | -0.7% | 316,800 |
| 2020/02/04 | 3,930 | 3,945 | 3,700 | 3,750 | -260 | -6.5% | 511,800 |
| 2020/02/03 | 4,210 | 4,285 | 3,930 | 4,010 | -145 | -3.5% | 647,300 |
| 2020/01/31 | 4,165 | 4,360 | 3,940 | 4,155 | +90 | +2.2% | 740,500 |
| 2020/01/30 | 3,900 | 4,540 | 3,900 | 4,065 | +130 | +3.3% | 2,762,400 |
| 2020/01/29 | 4,080 | 4,120 | 3,865 | 3,935 | -120 | -3% | 795,200 |
| 2020/01/28 | 4,460 | 4,465 | 3,985 | 4,055 | -365 | -8.3% | 1,409,000 |
| 2020/01/27 | 4,180 | 4,480 | 4,095 | 4,420 | +410 | +10.2% | 1,340,500 |
| 2020/01/24 | 4,200 | 4,245 | 3,925 | 4,010 | -100 | -2.4% | 581,700 |
| 2020/01/23 | 3,995 | 4,160 | 3,905 | 4,110 | +160 | +4.1% | 611,900 |
| 2020/01/22 | 4,260 | 4,340 | 3,920 | 3,950 | +60 | +1.5% | 783,100 |
| 2020/01/21 | 3,730 | 3,975 | 3,715 | 3,890 | +275 | +7.6% | 413,800 |
| 2020/01/20 | 3,560 | 3,630 | 3,485 | 3,615 | +125 | +3.6% | 111,200 |
| 2020/01/17 | 3,565 | 3,565 | 3,440 | 3,490 | -55 | -1.6% | 98,800 |
| 2020/01/16 | 3,680 | 3,740 | 3,515 | 3,545 | +60 | +1.7% | 279,600 |
| 2020/01/15 | 3,475 | 3,550 | 3,465 | 3,485 | -50 | -1.4% | 100,800 |
| 2020/01/14 | 3,735 | 3,740 | 3,515 | 3,535 | +50 | +1.4% | 125,600 |
| 2020/01/10 | 3,310 | 3,495 | 3,310 | 3,485 | +205 | +6.3% | 135,600 |
| 2020/01/09 | 3,265 | 3,315 | 3,235 | 3,280 | +65 | +2% | 41,700 |
| 2020/01/08 | 3,255 | 3,255 | 3,195 | 3,215 | -70 | -2.1% | 55,600 |
| 2020/01/07 | 3,215 | 3,295 | 3,215 | 3,285 | +35 | +1.1% | 59,700 |
| 2020/01/06 | 3,205 | 3,260 | 3,200 | 3,250 | -25 | -0.8% | 52,900 |
| 2019/12/30 | 3,255 | 3,300 | 3,200 | 3,275 | +50 | +1.6% | 63,900 |
| 2019/12/27 | 3,190 | 3,260 | 3,175 | 3,225 | +35 | +1.1% | 60,800 |
| 2019/12/26 | 3,205 | 3,230 | 3,155 | 3,190 | -15 | -0.5% | 32,100 |
| 2019/12/25 | 3,245 | 3,245 | 3,190 | 3,205 | -45 | -1.4% | 32,700 |
| 2019/12/24 | 3,255 | 3,295 | 3,235 | 3,250 | -5 | -0.2% | 34,700 |
| 2019/12/23 | 3,315 | 3,315 | 3,195 | 3,255 | -25 | -0.8% | 81,200 |
| 2019/12/20 | 3,215 | 3,330 | 3,210 | 3,280 | +85 | +2.7% | 89,600 |
| 2019/12/19 | 3,185 | 3,275 | 3,180 | 3,195 | +30 | +0.9% | 88,400 |
| 2019/12/18 | 3,120 | 3,170 | 3,090 | 3,165 | +50 | +1.6% | 77,300 |
1301～
1350
件表示中 / 3983件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 31,100円 | +0.1% | -70.9% | 0.00% | 52.00倍 | 1.96倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| 扶桑薬 | 212,700円 | +1.6% | -12.7% | 4.23% | 7.90倍 | 0.55倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,900円 | - | - | 0.00% | - | 2.85倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| オンコリス | 63,500円 | +3771.0% | - | 0.00% | - | 5.75倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 21,200円 | - | - | 0.00% | - | 4.51倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
